EcoDrugPlus

Integrin Subunit Beta 7

Ensembl ID : ENSMMNG00015015947
Gene Symbol: ITGB7
3 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSMMNG00015014541
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSMMNG00015021230
Gene Symbol: ICAM1
3 Cross references
93 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSMMNG00015018774
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSMMNG00015001244
Gene Symbol: IL5
3 Cross references
91 Possible Orthologues:

Interleukin 6

Ensembl ID : ENSMMNG00015013785
Gene Symbol: IL6
1 Cross references
162 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSMMNG00015008654
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSMMNG00015008143
Gene Symbol: IDH2
3 Cross references
261 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSMMNG00015000719
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSMMNG00015013066
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSMMNG00015014591
Gene Symbol: KIF11
1 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSMMNG00015010082
Gene Symbol: KIF5B
3 Cross references
281 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).